BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 19715828)

  • 1. Renal allografts from donors older than 70 years are useful for single transplantation.
    Gavela E; Pallardó LM; Avila A; Sancho A; Beltrán S; Kanter J; Crespo JF
    Transplant Proc; 2009; 41(6):2047-9. PubMed ID: 19715828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction treatment with low-dose thymoglobulin or basiliximab in renal transplants from older donors.
    Gavela Martínez E; Sancho Calabuig A; Escudero Quesada V; Avila Bernabeu AI; Beltrán Catalán S; Morales García AI; Crespo Albiach JF; Pallardó Mateu LM
    Transplant Proc; 2008 Nov; 40(9):2900-2. PubMed ID: 19010141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histological findings of early graft biopsies in old donor renal transplant patients receiving induction therapy.
    Gavela E; Pallardó LM; Sancho A; Avilla A; Beltrán S; Roselló E; Pérez ML; García F
    Transplant Proc; 2009; 41(6):2099-101. PubMed ID: 19715842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction Immunosuppressive Therapy Use in Deceased Donor Kidney Transplantation: 11-Year Experience in Veracruz, Mexico.
    Martinez-Mier G; Soto-Miranda E; Avila-Pardo SF; Budar-Fernandez LF; Mateu-Rivera LJ; Mendez-Lopez MT; Trujillo-Martinez MF; Uscanga-Montesano A; Avila Y Falfan D
    Transplant Proc; 2016 Mar; 48(2):600-4. PubMed ID: 27110011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immediate graft function positively affects long-term outcome of renal allografts from older but not from younger donors.
    Messa P; Brezzi B; Cresseri D; Berardinelli L; Poli F; Scalamogna M; Tripepi G; Ponticelli C
    Transplant Proc; 2006 Dec; 38(10):3377-81. PubMed ID: 17175276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delayed graft function in renal transplant recipients: risk factors and impact on 1-year graft function: a single center analysis.
    Bronzatto EJ; da Silva Quadros KR; Santos RL; Alves-Filho G; Mazzali M
    Transplant Proc; 2009 Apr; 41(3):849-51. PubMed ID: 19376369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction with basiliximab plus thymoglobulin is effective and safe in old-for-old renal transplantation: six-month results of a prospective clinical study.
    Favi E; Gargiulo A; Spagnoletti G; Salerno MP; Silvestrini N; Valente I; Citterio F
    Transplant Proc; 2010 May; 42(4):1114-7. PubMed ID: 20534237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of basiliximab induction in low-immunological risk renal transplant recipients receiving tacrolimus-based immunosuppression.
    Gavela Martínez E; Avila Bernabeu AI; Sancho Calabuig A; Beltrán Catalán S; Escudero Quesada V; Pallardó Mateu LM
    Transplant Proc; 2009; 41(6):2337-8. PubMed ID: 19715913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double versus single renal allografts from aged donors.
    Andrés A; Morales JM; Herrero JC; Praga M; Morales E; Hernández E; Ortuño T; Rodício JL; Martínez MA; Usera G; Díaz R; Polo G; Aguirre F; Leiva O
    Transplantation; 2000 May; 69(10):2060-6. PubMed ID: 10852597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basiliximab (Simulect) in renal transplantation with high risk for delayed graft function.
    Fernandez Rivera C; Alonso Hernandez A; Villaverde Verdejo P; Oliver García J; Valdés Cañedo F
    Transplant Proc; 2005 Apr; 37(3):1435-7. PubMed ID: 15866629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of donor age on renal allograft function and survival.
    Resende L; Guerra J; Santana A; Mil-Homens C; Abreu F; da Costa AG
    Transplant Proc; 2009 Apr; 41(3):794-6. PubMed ID: 19376354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 20-year follow-up results of a randomized controlled trial comparing antilymphocyte globulin induction to no induction in renal transplant patients.
    Cantarovich M; Durrbach A; Hiesse C; Ladouceur M; Benoit G; Charpentier B
    Transplantation; 2008 Dec; 86(12):1732-7. PubMed ID: 19104413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Very low-grade proteinuria at 3 months posttransplantation is an earlier marker of graft survival.
    Sancho Calabuig A; Pallardó Mateu LM; Avila Bernabeu AI; Gavela Martínez E; Beltrán Catalán S; Crespo Albiach JF
    Transplant Proc; 2009; 41(6):2122-5. PubMed ID: 19715850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcineurin inhibitor-free immunosuppressive strategy in elderly recipients of renal allografts from deceased donors: 1-year results from a prospective single center trial.
    Arbogast HP; Hoffmann JN; Illner WD; Hillebrand GF; Fischereder M; Jauch KW; Land W
    Transplant Proc; 2009; 41(6):2529-32. PubMed ID: 19715968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal retransplantation: a retrospective monocentric study.
    Ott U; Busch M; Steiner T; Schubert J; Wolf G
    Transplant Proc; 2008 Jun; 40(5):1345-8. PubMed ID: 18589102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The LifeLink Foundation and cadaver kidney transplantation in Tampa.
    LeFor WM; Wright CE; Bowers VD; Heinrichs DF; Shires DL
    Clin Transpl; 1999; ():149-58. PubMed ID: 11038633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of the using older donors for kidney transplantation;Gazi University, Ankara experience.
    Sözen H; Fidan K; Onaran M; Arinsoy T; Dalgiç A
    Transplant Proc; 2010 Sep; 42(7):2477-8. PubMed ID: 20832527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The risk factors of delayed graft function and comparison of clinical outcomes after deceased donor kidney transplantation: single-center study.
    Jung GO; Yoon MR; Kim SJ; Sin MJ; Kim EY; Moon JI; Kim JM; Choi GS; Kwon CH; Cho JW; Lee SK
    Transplant Proc; 2010 Apr; 42(3):705-9. PubMed ID: 20430152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Basiliximab versus daclizumab combined with triple immunosuppression in deceased donor renal graft recipients.
    Grego K; Arnol M; Bren AF; Kmetec A; Tomaziĉ J; Kandus A
    Transplant Proc; 2007 Dec; 39(10):3093-7. PubMed ID: 18089329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delayed graft function has an equally bad impact on deceased donor renal graft survival in both standard criteria donors and expanded criteria donors.
    Hassanain M; Tchervenkov J; Cantarovich M; Metrakos P; Paraskevas S; Keith D; Baran D; Fernandez M; Mangel R; Chaudhury P
    Transplant Proc; 2009; 41(1):133-4. PubMed ID: 19249497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.